Accessibility Menu
Biote Stock Quote

Biote (NASDAQ: BTMD)

$1.44
(4.0%)
+0.06
Price as of March 17, 2026, 11:21 a.m. ET

KEY DATA POINTS

Current Price
$1.44
Daily Change
(4.0%) +$0.06
Day's Range
$1.38 - $1.47
Previous Close
$1.39
Open
$1.40
Beta
N/A
Volume
7,765
Average Volume
178,648
Market Cap
$45M
Market Cap / Employee
$1.39M
52wk Range
$1.38 - $4.75
Revenue
N/A
Gross Margin
0.70%
Dividend Yield
N/A
EPS
$0.76
CAPs Rating
N/A
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Biote Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
BTMD-63.16%N/AN/A-86%
S&P+18.81%+68.58%+11.01%+60%

Biote Company Info

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company is headquartered in Irving, TX.

News & Analysis

No results found

No news articles found for Biote.

Financial Health

General

Q4 2025YOY Change
Revenue$46.41M-6.9%
Gross Profit$30.82M-11.1%
Gross Margin66.42%-3.1%
Market Cap$83.90M-58.5%
Market Cap / Employee$376.22K0.0%
Employees2232.8%
Net Income$2.62M-24.9%
EBITDA$8.17M-28.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q4 2025YOY Change
Net Cash$24.12M-38.7%
Accounts Receivable$6.87M-10.0%
Inventory19.410.0%

Liabilities

Q4 2025YOY Change
Long Term Debt$103.08M-30.5%
Short Term Debt$25.34M-19.2%

Ratios

Q4 2025YOY Change
Return On Assets23.52%19.2%
Return On Invested Capital38.94%-10.5%

Cash Flow

Q4 2025YOY Change
Free Cash Flow$6.49M-39.3%
Operating Free Cash Flow$7.57M-38.8%

Valuation

MetricQ1 2025Q2 2025Q3 2025Q4 2025YoY Change
Price to Earnings5.454.453.783.43-90.00%
Price to Book-0.99-1.41-1.12-1.10-25.67%
Price to Sales0.620.640.560.42-64.32%
Price to Tangible Book Value-0.87-1.21-0.96-0.92-29.86%
Price to Free Cash Flow TTM3.893.903.372.82-58.35%
Enterprise Value to EBITDA23.5121.4724.5023.58-28.32%
Free Cash Flow Yield25.7%25.6%29.7%35.5%140.12%
Total Debt$179.32M$153.67M$146.87M$128.42M-28.55%

No results found

No podcast episodes available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.